Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer

Sponsor
National Cancer Center, Korea
Study ID
NCT06730893
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Papillary Thyroid Carcinoma
  • Thyroid Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • SDM protocol — OTHER
    Card news and Videos related to general knowledge and treatment of low-risk thyroid cancer

Study Details

This study is a multicenter cluster-randomized controlled trial conducted in Korea. A parallel, two-group cluster-randomized design will be used to test whether the Shared decision-making Group (SDM; intervention) is different from the Standard Care Group (SC; control).

Key Dates

First listed
Dec 12, 2024
Start date
May 12, 2025
Status verified
Apr 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
310 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: SDM Group (Shared Decision-Making Group; Intervention Group)
    * Patients will receive detailed information, including an information leaflet about treatment options. * Clinicians will guide patients through a structured SDM protocol before finalizing the treatment decision.
  • No Intervention: SC Group (Standard Care Group; Control Group)
    \- Patients will receive standard medical care following current clinical practices without the SDM protocol.

Primary Outcome Measure

Decision Conflict Scale: DCS [ Time Frame: at enrollment ]

Central Contacts

Related Studies